Veru Inc. (NASDAQ: VERU)
$0.97
+0.0186 ( +1.96% ) 170.8K
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
Market Data
Open
$0.97
Previous close
$0.95
Volume
170.8K
Market cap
$143.37M
Day range
$0.95 - $0.98
52 week range
$0.36 - $1.92
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 02, 2024 |
8-k | 8K-related | 13 | Jun 21, 2024 |
4 | Insider transactions | 1 | May 28, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
8-k | 8K-related | 17 | May 22, 2024 |
4 | Insider transactions | 1 | May 17, 2024 |
4 | Insider transactions | 1 | May 17, 2024 |
4 | Insider transactions | 1 | May 09, 2024 |
4 | Insider transactions | 1 | May 09, 2024 |